HEATHER POPPELL: Open Payments
NPI 1184281057 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 80 payments from 24 companies in 2025. Trend: 2023 $1,828 · 2024 $1,942 · 2025 $1,943
Food & beverage: $1,932Education: $11
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 6 | $248 |
| Insmed, Inc. | 12 | $233 |
| Aimmune Therapeutics, Inc. | 8 | $206 |
| Merck Sharp & Dohme LLC | 8 | $190 |
| Gilead Sciences, Inc. | 7 | $168 |
| ViiV Healthcare Company | 5 | $135 |
| Smith+Nephew, Inc. | 4 | $122 |
| ABBVIE INC. | 5 | $111 |
| MIMEDX Group, Inc. | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
Products named: QUTENZA, Arikayce, VOWST, ZERBAXA, RUKOBIA, MAVYRET, PIFELTRO, COLLAGENASE SANTYL.
Industry payments across FL — which companies pay providers there.
